Modalis is a biotech company that utilizes CRISPR technology to develop targeted therapeutics for genetic disorders, specifically focusing on conditions like congenital muscular dystrophy. Their approach aims to provide precise gene editing solutions to address the underlying genetic causes of these diseases.
Funding
$25M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
UIFounders
Product
Problem
Genetic disorders like congenital muscular dystrophy lack effective treatments that address the underlying genetic mutations. Current therapeutic options often manage symptoms without correcting the root cause of the disease. This leaves a significant unmet need for targeted therapies that can precisely modify disease-causing genes.
Solution
Modalis is developing CRISPR-based therapeutics to target and correct genetic mutations responsible for congenital muscular dystrophy and other genetic disorders. Their approach utilizes gene editing technology to precisely modify the disease-causing genes, offering the potential for long-lasting therapeutic effects. By directly addressing the genetic origin of these diseases, Modalis aims to provide more effective and potentially curative treatment options compared to traditional symptom management. Their lead candidate, MDL-101, is being developed as a treatment for congenital muscular dystrophy type 1A (LAMA2-CMD).
Target Audience
The primary target audience includes patients suffering from genetic disorders, particularly congenital muscular dystrophy, and their families, as well as healthcare providers specializing in genetic diseases.
Features
- CRISPR-based gene editing technology for targeted correction of genetic mutations
- Focus on developing therapeutics for genetic disorders, including congenital muscular dystrophy
- Lead candidate, MDL-101, for the treatment of LAMA2-CMD
- Aims to provide long-lasting therapeutic effects by directly addressing the genetic origin of diseases